Italy Central Lab Market Size & Outlook, 2025-2030
Related Markets
Italy central lab market highlights
- The Italy central lab market generated a revenue of USD 94.7 million in 2024 and is expected to reach USD 144.2 million by 2030.
- The Italy market is expected to grow at a CAGR of 7.4% from 2025 to 2030.
- In terms of segment, biomarker services was the largest revenue generating services in 2024.
- Anatomic Pathology/Histology is the most lucrative services segment registering the fastest growth during the forecast period.
Central lab market data book summary
| Market revenue in 2024 | USD 94.7 million |
| Market revenue in 2030 | USD 144.2 million |
| Growth rate | 7.4% (CAGR from 2025 to 2030) |
| Largest segment | Biomarker services |
| Fastest growing segment | Anatomic Pathology/Histology |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services |
| Key market players worldwide | LabConnect, Eurofins Scientific SE, A. P. Moller Maersk A/S ADR, ACM Global, Cerba Research, Synevo Central Labs, Versiti, Cenetron, Ampersand Capital Partners, Pacific Biomarkers, Cirion |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global central lab market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany central lab market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 190.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Central Lab Market Scope
Central Lab Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cirion | View profile | 101-250 | Laval, Quebec, Canada, North America | https://www.cirion.com |
| Pacific Biomarkers | View profile | 51-100 | Seattle, Washington, United States, North America | http://www.pacbio.com |
| Ampersand Capital Partners | View profile | 11-50 | Wellesley, Massachusetts, United States, North America | http://www.ampersandcapital.com |
| Cenetron | View profile | 101-250 | Austin, Texas, United States, North America | https://www.cenetron.com/ |
| Versiti | View profile | 1001-5000 | Milwaukee, Wisconsin, United States, North America | https://www.versiti.org/ |
| Synevo Central Labs | View profile | - | Waterloo, Brabant Wallon, Belgium, Europe | http://www.synevo-centrallabs.eu |
| Cerba Research | View profile | 5001-10000 | Ghent, Oost-Vlaanderen, Belgium, Europe | https://www.cerbaresearch.com |
| ACM Global | View profile | 251-500 | Rochester, New York, United States, North America | http://www.acmgloballab.com |
| LabConnect | View profile | 101-250 | Johnson City, Tennessee, United States, North America | https://www.labconnect.com/ |
| A. P. Moller Maersk A/S ADR | View profile | 100000 | Esplanaden 50, Copenhagen, Denmark, 1263 | https://www.maersk.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
Italy central lab market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central lab market will help companies and investors design strategic landscapes.
Biomarker services was the largest segment with a revenue share of 41.29% in 2024. Horizon Databook has segmented the Italy central lab market based on genetic services, biomarker services, microbiology services, anatomic pathology/histology, specimen management & storage, special chemistry services covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing geriatric population and rising prevalence of chronic diseases in Italy are some of the key factors driving the market growth. The country has the third oldest population worldwide, with over 23% of Italians being aged 65 and older in 2020.
Furthermore, the average age of the population is around 45.7 years. The country is home to over 60 million residents, making it an attractive destination for various clinical studies. Favorable government initiatives and rising support for undertaking clinical research are further expected to boost market growth over the forecast period.
For instance, Italian Medicines Agency (AIFA) issues clinical trial guidance and GCP compliance measures for trial sponsors & trial partners and supports clinical development in the country. Furthermore, Italy registered about 15,428 clinical studies involving Italian trial sites on clinicaltrials.gov by June 2021, and the number is expected to grow in the near future.
Reasons to subscribe to Italy central lab market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy central lab market databook
-
Our clientele includes a mix of central lab market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy central lab market , including forecasts for subscribers. This country databook contains high-level insights into Italy central lab market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy central lab market size, by services, 2018-2030 (US$M)
Italy Central Lab Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
